Som Datt Finance (511571)
Fast GrowerScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹113.2 |
| Market Cap | ₹113.29 Cr |
| P/E Ratio | 755.57 |
| ROCE | -17.84% |
| ROE | 0.75% |
| Dividend Yield | 0% |
| Profit Growth | 127.74% |
| Debt/Equity | — |
| Sales Growth | 187.12% |
| 52-Week Range | ₹96.05 — ₹144.7 |
| Sector | Finance |
| Book Value | ₹24.19 |
Strengths
- Sales growth of 187.12% and profit growth of 127.74% show recent momentum.
- Latest quarter is profitable: sales ₹4 Cr and net profit ₹1 Cr.
- Piotroski F-Score of 6/9 suggests moderate fundamental soundness.
- Debt/Equity is N/A, implying the company may be debt-free or has negligible debt.
Concerns
- Extremely high P/E of 755.57 means valuation is far ahead of earnings.
- ROE of only 0.75% shows poor return on shareholders' equity.
- Negative ROCE of -17.84% indicates inefficient capital deployment.
- No dividend yield (0.00%) and 52-week range shows a volatile, speculative stock.
AI Analysis
At ₹113.20, Som Datt Finance demands ₹113 crore for a business that earned just ₹1 crore last quarter. That's a P/E of 755 — meaning you'd wait 755 years for the company to earn back your purchase price at current profits. This is not investing; it's hope. The sales growth of 187% and profit growth of 128% look spectacular, but they are from a minuscule base. Quarterly sales of ₹4 crore and net profit of ₹1 crore are not a moat. As Graham said, 'The investor's chief problem—and even his worst enemy—is to be wrong about the future.' Here, the price already assumes a perfect future. Book value is ₹24.19, so you pay 4.68 times the net assets for a return on equity of just 0.75%. That's a shocking mismatch. A rupee of equity earns less than a rupee in a savings account. ROCE is negative at -17.84%, suggesting operating inefficiency or poor capital allocation. The company pays no dividend, so the only possible return comes from price appreciation. The Piotroski F-Score of 6 offers some reassurance, but it doesn't justify the valuation. I cannot call this a wonderful business. There's no durable competitive advantage visible, and the financial health metrics are weak. This looks more like a speculative vehicle than a compounding machine. As Buffett would say, 'The trick is not to learn to trust your gut instincts, but rather to discipline yourself to ignore them.' The gut might be excited by growth, but the calculator says otherwise. For value investors, patience is better than paying 755 times earnings for an ordinary NBFC.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer